Skip to main content
. 2021 Oct 31;33(5):616–626. doi: 10.21147/j.issn.1000-9604.2021.05.08

Table 4. Best ORR for evaluable subjects.

Best overall response n (%)
Chidamide 20 mg + CHOP (n=8) Chidamide 25 mg + CHOP (n=9) Chidamide 30 mg + CHOP (n=9) Chidamide 35 mg + CHOP (n=2) Total (N=28)
ORR, overall response rate; CR, complete response; CRu, unconfirmed complete response; PR, partial response; SD, stable disease; PD, progressive disease; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone.
Overall response 8 (100) 7 (77.8) 9 (100) 1 (50.0) 25 (89.3)
CR or CRu 4 (50.0) 5 (55.6) 7 (77.8) 0 (0) 16 (57.1)
PR 4 (50.0) 2 (22.2) 2 (22.2) 1 (50.0) 9 (32.1)
SD 0 (0) 2 (22.2) 0 (0) 0 (0) 2 (7.2)
PD 0 (0) 0 (0) 0 (0) 1 (50.0) 1 (3.6)